A detailed history of Prelude Capital Management, LLC transactions in Quanterix Corp stock. As of the latest transaction made, Prelude Capital Management, LLC holds 19,300 shares of QTRX stock, worth $220,792. This represents 0.02% of its overall portfolio holdings.

Number of Shares
19,300
Previous 19,300 -0.0%
Holding current value
$220,792
Previous $249,000 -0.0%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.92 - $16.36 $2,129 - $3,190
195 Added 1.02%
19,300 $249,000
Q2 2024

Aug 14, 2024

SELL
$12.26 - $23.78 $4,805 - $9,321
-392 Reduced 2.01%
19,105 $252,000
Q1 2024

May 15, 2024

BUY
$21.9 - $28.28 $21,374 - $27,601
976 Added 5.27%
19,497 $459,000
Q4 2023

Feb 14, 2024

SELL
$19.54 - $28.66 $115,930 - $170,039
-5,933 Reduced 24.26%
18,521 $506,000
Q3 2023

Nov 14, 2023

SELL
$21.15 - $27.96 $4,441 - $5,871
-210 Reduced 0.85%
24,454 $663,000
Q2 2023

Aug 14, 2023

BUY
$11.16 - $23.65 $275,250 - $583,303
24,664 New
24,664 $556,000
Q4 2022

Feb 14, 2023

BUY
$8.75 - $14.02 $71,618 - $114,753
8,185 Added 42.43%
27,475 $380,000
Q3 2022

Nov 14, 2022

BUY
$7.46 - $19.28 $143,903 - $371,911
19,290 New
19,290 $213,000
Q1 2020

May 15, 2020

SELL
$11.17 - $28.72 $380,774 - $979,036
-34,089 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$19.29 - $25.52 $83,101 - $109,940
-4,308 Reduced 11.22%
34,089 $806,000
Q3 2019

Nov 14, 2019

BUY
$21.72 - $35.38 $439,525 - $715,949
20,236 Added 111.43%
38,397 $843,000
Q2 2019

Aug 14, 2019

BUY
$20.59 - $35.2 $343,894 - $587,910
16,702 Added 1144.76%
18,161 $614,000
Q1 2019

May 15, 2019

BUY
$17.28 - $25.83 $25,211 - $37,685
1,459 New
1,459 $38,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $423M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.